Ignite Creation Date:
2024-05-05 @ 5:05 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00381641
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-08
First Post:
2006-09-26
Brief Title:
Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Unresectable Thyroid Gland Carcinoma |
| Differentiated Thyroid Gland Carcinoma |
| Recurrent Thyroid Gland Carcinoma |
| Refractory Thyroid Gland Carcinoma |
| Stage III Thyroid Gland Follicular Carcinoma AJCC v7 |
| Stage III Thyroid Gland Medullary Carcinoma AJCC v7 |
| Stage IV Thyroid Gland Follicular Carcinoma AJCC v7 |
| Stage IV Thyroid Gland Medullary Carcinoma AJCC v7 |
| Stage IV Thyroid Gland Papillary Carcinoma AJCC v7 |
| Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7 |
| Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7 |
| Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7 |
| Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7 |
| Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7 |
| Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7 |
| Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7 |
| Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7 |
| Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7 |
| Thyroid Gland Oncocytic Carcinoma |
Keywords: